target

King’s College London Researchers Identify Breakthrough Multi-Target Drug Candidate KCL-286 for Early Stage Alzheimer’s Treatment

In a significant departure from traditional amyloid-centric research, a team of neuroscientists at King’s College London (KCL) has unveiled a…